These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 350730

  • 21. [The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide].
    Kaiser B, Hauptmann J, Markwardt F.
    Pharmazie; 1987 Feb; 42(2):119-21. PubMed ID: 3602050
    [Abstract] [Full Text] [Related]

  • 22. Degradation of a benzamidine-type synthetic inhibitor of coagulation enzymes in plasma of various species.
    Hauptmann J.
    Thromb Res; 1991 Feb 01; 61(3):279-84. PubMed ID: 2028446
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of four human serine proteases by substituted benzamidines.
    Andrews JM, Roman DP, Bing DH.
    J Med Chem; 1978 Dec 01; 21(12):1202-7. PubMed ID: 152812
    [Abstract] [Full Text] [Related]

  • 24. Interactions of thrombin with benzamidine-based inhibitors.
    Stürzebecher J, Vieweg H, Wikström P, Turk D, Bode W.
    Biol Chem Hoppe Seyler; 1992 Jul 01; 373(7):491-6. PubMed ID: 1515080
    [Abstract] [Full Text] [Related]

  • 25. Synthetic inhibitors of serine proteinases. XXIII. Inhibition of factor Xa by diamidines.
    Stürzebecher J, Markwardt F, Walsmann P.
    Thromb Res; 1992 Jul 01; 17(3-4):545-8. PubMed ID: 6989016
    [No Abstract] [Full Text] [Related]

  • 26. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M, Bode W, Huber R, Stürzebecher J, Stubbs MT.
    J Med Chem; 1998 Dec 31; 41(27):5445-56. PubMed ID: 9876114
    [Abstract] [Full Text] [Related]

  • 27. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D, Schweinitz A, Stürzebecher A, Steinmetzer P, Schuster M, Stürzebecher U, Nicklisch S, Stürzebecher J, Steinmetzer T.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3322-9. PubMed ID: 17462889
    [Abstract] [Full Text] [Related]

  • 28. [Synthetic inhibitors of serine proteinases. 12. The inhibition of trypsin, plasmin and thrombin by 3-[amidinophenyl]-1-phenyl-propanone-(1) with substituents in the aliphatic intermediate chain].
    Walsmann P, Griessmann R, Horn H, Markwardt F, Richter P, Stürzebecher J, Wagner G.
    Pharmazie; 1976 Jun 15; 31(6):410-1. PubMed ID: 134380
    [No Abstract] [Full Text] [Related]

  • 29. Inhibition of acrosin by benzamidines.
    Stürzebecher J.
    Acta Biol Med Ger; 1981 Jun 15; 40(10-11):1519-22. PubMed ID: 7044006
    [Abstract] [Full Text] [Related]

  • 30. In vitro and in vivo comparison of arginine- and benzamidine-derived highly potent synthetic thrombin inhibitors.
    Hauptmann J, Kaiser B.
    Pharmazie; 1991 Jan 15; 46(1):57-8. PubMed ID: 1857734
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacology of benzamidine-type thrombin inhibitors.
    Hauptmann J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Jan 15; 109(1):89-97. PubMed ID: 6177614
    [Abstract] [Full Text] [Related]

  • 32. [Free-Wilson analysis of the inhibitory effect of 4-substituted benzamidines on thrombin, plasmin and trypsin (author's transl)].
    Labes D, Hagen V.
    Pharmazie; 1979 Jan 15; 34(9):554-6. PubMed ID: 161622
    [Abstract] [Full Text] [Related]

  • 33. [Hansch analysis of the inhibitory action of 3- and 4-substituted benzamidines on thrombin, plasmin and trypsin (author's transl)].
    Labes D, Hagen V.
    Pharmazie; 1979 Oct 15; 34(10):649-53. PubMed ID: 161621
    [Abstract] [Full Text] [Related]

  • 34. Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
    Hijikata A, Okamoto S, Kikumoto R, Tamao Y.
    Thromb Haemost; 1979 Oct 31; 42(3):1039-45. PubMed ID: 159513
    [Abstract] [Full Text] [Related]

  • 35. Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
    Baker BR, Erickson EH.
    J Med Chem; 1969 Jan 31; 12(1):112-7. PubMed ID: 5763005
    [No Abstract] [Full Text] [Related]

  • 36. Leupeptins, new protease inhibitors from Actinomycetes.
    Aoyagi T, Takeuchi T, Matsuzaki A, Kawamura K, Kondo S.
    J Antibiot (Tokyo); 1969 Jun 31; 22(6):283-6. PubMed ID: 5810993
    [No Abstract] [Full Text] [Related]

  • 37. [Synthetic inhibitors of serine proteinases. 5. The inhibition of trypsin, plasmin and thrombin caused by aliphatic amidino compounds having ether structure as well as esters of the 3- and 4-amidinophenoxyfacetic acid].
    Walsmann P, Horn H, Landmann H, Markwardt F, Stürzebecher J, Wagner G.
    Pharmazie; 1975 Jun 31; 30(6):386-9. PubMed ID: 125879
    [No Abstract] [Full Text] [Related]

  • 38. Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine.
    Stürzebecher J, Prasa D, Hauptmann J, Vieweg H, Wikström P.
    J Med Chem; 1997 Sep 12; 40(19):3091-9. PubMed ID: 9301673
    [Abstract] [Full Text] [Related]

  • 39. Diamidino-alpha,omega-diphenoxyalkanes. Structure-activity relationships for the inhibition of thrombin, pancreatic kallikrein, and trypsin.
    Geratz JD, Whitmore AC.
    J Med Chem; 1973 Sep 12; 16(9):970-5. PubMed ID: 4795664
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacologic control of blood coagulation by synthetic, low molecular weight inhibitors of clotting enzymes.
    Markwardt F.
    Ann N Y Acad Sci; 1981 Sep 12; 370():757-64. PubMed ID: 7023330
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.